Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above
Clinical trial NCT02126761 · COMPLETED
Trial details
- NCT number
- NCT02126761
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-11-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.